Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
Open Access
- 4 December 2009
- journal article
- review article
- Published by Springer Nature in BMC Neurology
- Vol. 9 (1) , 59
Abstract
Cannabis therapy has been considered an effective treatment for spasticity, although clinical reports of symptom reduction in multiple sclerosis (MS) describe mixed outcomes. Recently introduced therapies of combined Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extracts have potential for symptom relief with the possibility of reducing intoxication and other side effects. Although several past reviews have suggested that cannabinoid therapy provides a therapeutic benefit for symptoms of MS, none have presented a methodical investigation of newer cannabinoid treatments in MS-related spasticity. The purpose of the present review was to systematically evaluate the effectiveness of combined THC and CBD extracts on MS-related spasticity in order to increase understanding of the treatment's potential effectiveness, safety and limitations.Keywords
This publication has 25 references indexed in Scilit:
- Cannabinoid System and Neuroinflammation: Implications for Multiple SclerosisNeuroimmunomodulation, 2007
- Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related painJournal of Neurology, 2006
- Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosisMultiple Sclerosis Journal, 2006
- Combined cannabinoid therapy via an oromucosal sprayDrugs of Today, 2006
- Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover studyMultiple Sclerosis Journal, 2004
- Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patientsMultiple Sclerosis Journal, 2004
- Medicinal cannabis extracts for the treatment of multiple sclerosis.2004
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Cannabinoids in Clinical PracticeDrugs, 2000